{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:45:54Z","timestamp":1791852354315,"version":"4.3.4"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971504"],"award-info":[{"award-number":["81971504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Recent evidence suggests the global incidence and mortality of hepatocellular carcinoma (HCC) are increasing. Although the highest incidence of HCC remains entrenched in WHO regions with high levels of HBV-HCV infection, the etiology of this disease is rapidly changing to include other lifestyle risk factors. Extrahepatic metastasis is a frequent feature of advanced HCC and most commonly locates in the lungs and bone. Bone metastasis in HCC (HCC-BM) signals a more aggressive stage of disease and a poorer prognosis, simultaneously HCC-BM compromises the function and integrity of bone tissue. HCC induced osteolysis is a prominent feature of metastasis that complicates treatment needed for pathologic fractures, bone pain and other skeletal events like hypercalcemia and nerve compression. Early detection of bone metastases facilitates the treatment strategy for avoiding and relieving complications. Although recent therapeutic advances in HCC like targeting agents and immunotherapy have improved survival, the prognosis for patients with HCC-BM remains problematic. The identification of critical HCC-BM pathways in the bone microenvironment could provide important insights to guide future detection and therapy. This review presents an overview of the clinical development of bone metastases in HCC, identifying key clinical features and identifying potential molecular targets that can be deployed as diagnostic tools or therapeutic agents.<\/jats:p>","DOI":"10.3389\/fonc.2022.943866","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T03:49:41Z","timestamp":1656474581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaofeng","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xubin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32723","article-title":"International Trends in Hepatocellular Carcinoma Incidence, 1978\u20132012","volume":"147","author":"Petrick","year":"2020","journal-title":"Int J Cancer."},{"key":"B4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing Cancer Survival in China During 2003-15: A Pooled Analysis of 17 Population-Based Cancer Registries","volume":"6","author":"Zeng","year":"2018","journal-title":"Lancet Glob Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000246","article-title":"(1)(8)F-FDG PET\/CT in Hepatocellular Carcinoma: Detection of Bone Metastasis and Prediction of Prognosis","volume":"36","author":"Seo","year":"2015","journal-title":"Nucl Med Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2007.39.3.104","article-title":"Bone Metastasis From Primary Hepatocellular Carcinoma: Characteristics of Soft Tissue Formation","volume":"39","author":"Kim","year":"2007","journal-title":"Cancer Res Treat"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1097\/TXD.0000000000000846","article-title":"Value of Bone Scans in Work-Up of Patients With Hepatocellular Carcinoma for Liver Transplant","volume":"4","author":"Kutaiba","year":"2018","journal-title":"Transplant Direct."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.03919.x","article-title":"Clinical Features of Hepatocellular Carcinoma With Extrahepatic Metastases","volume":"20","author":"Natsuizaka","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2019.00136","article-title":"Prognostic Factors in Hepatocellular Carcinoma Patients With Bone Metastases","volume":"37","author":"Kim","year":"2019","journal-title":"Radiat Oncol J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200109000-00015","article-title":"Increased Incidence of Bone Metastases in Hepatocellular Carcinoma","volume":"13","author":"Fukutomi","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.7024","article-title":"Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma","volume":"16","author":"Harding","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8254236","DOI":"10.1155\/2020\/8254236","article-title":"Hepatocellular Carcinoma: First Manifestation as Solitary Humeral Bone Metastasis","volume":"2020","author":"Bukhari","year":"2020","journal-title":"Case Rep Oncol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-013-9454-4","article-title":"Bone Metastases in Hepatocellular Carcinoma: An Emerging Issue","volume":"33","author":"Longo","year":"2014","journal-title":"Cancer Metastasis Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i15.1964","article-title":"Mechanisms of Hepatocellular Carcinoma and Challenges and Opportunities for Molecular Targeted Therapy","volume":"7","author":"Chen","year":"2015","journal-title":"World J Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature25432","article-title":"Chromosomal Instability Drives Metastasis Through a Cytosolic DNA Response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13046-017-0603-4","article-title":"Kindlin-2 Promotes Hepatocellular Carcinoma Invasion and Metastasis by Increasing Wnt\/beta-Catenin Signaling","volume":"36","author":"Lin","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New Insights Into the Mechanisms of Epithelial-Mesenchymal Transition and Implications for Cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of Resistance to Anti-Angiogenic Therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat Rev Cancer."},{"key":"B21","article-title":"A Possible Role of VEGF in Osteolytic Bone Metastasis of Hepatocellular Carcinoma","volume":"21","author":"Iguchi","year":"2002","journal-title":"J Exp Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65628-3","article-title":"Multistep Nature of Metastatic Inefficiency: Dormancy of Solitary Cells After Successful Extravasation and Limited Survival of Early Micrometastases","volume":"153","author":"Luzzi","year":"1998","journal-title":"Am J Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2513-1","article-title":"A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability","volume":"20","author":"Rodriguez-Peralvarez","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/cancers14071816","article-title":"Automatically Extracted Machine Learning Features From Preoperative CT to Early Predict Microvascular Invasion in HCC: The Role of the Zone of Transition (ZOT)","volume":"14","author":"Renzulli","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-194007000-00016","article-title":"The Function of the Vertebral Veins and Their Role in the Spread of Metastases","volume":"112","author":"Batson","year":"1940","journal-title":"Ann Surg"},{"key":"B26","article-title":"Perineural Invasion: A Potential Reason of Hepatocellular Carcinoma Bone Metastasis","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3390\/cancers13102476","article-title":"Clearance of Circulating Tumor Cells in Patients With Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation","volume":"13","author":"Amado","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12885-018-4744-4","article-title":"Effect of Surgical Liver Resection on Circulating Tumor Cells in Patients With Hepatocellular Carcinoma","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Cancer."},{"key":"B29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12943-019-1043-x","article-title":"Liquid Biopsy in Hepatocellular Carcinoma: Circulating Tumor Cells and Circulating Tumor DNA","volume":"18","author":"Ye","year":"2019","journal-title":"Mol Cancer."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007513","article-title":"The Diagnostic Value of Assays for Circulating Tumor Cells in Hepatocellular Carcinoma: A Meta-Analysis","volume":"96","author":"Sun","year":"2017","journal-title":"Med (Baltimore)."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-0234","article-title":"Molecular Biology of Bone Metastasis","volume":"6","author":"Kingsley","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone Metastasis: Mechanisms, Therapies, and Biomarkers","volume":"101","author":"Clezardin","year":"2021","journal-title":"Physiol Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.acr.2018.12.002","article-title":"Dormancy and Cancer Stem Cells: An Enigma for Cancer Therapeutic Targeting","volume":"141","author":"Talukdar","year":"2019","journal-title":"Adv Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00505","article-title":"Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis","volume":"8","author":"Yang","year":"2018","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/cancers11081207","article-title":"Tumor Cell Dormancy: Threat or Opportunity in the Fight Against Cancer","volume":"11","author":"Jahanban-Esfahlan","year":"2019","journal-title":"Cancers (Basel)."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0068","article-title":"Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State","volume":"77","author":"Manjili","year":"2017","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma","volume":"359","author":"Hoshida","year":"2008","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ccr.2006.06.016","article-title":"Prediction of Venous Metastases, Recurrence, and Prognosis in Hepatocellular Carcinoma Based on a Unique Immune Response Signature of the Liver Microenvironment","volume":"10","author":"Budhu","year":"2006","journal-title":"Cancer Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/1471-2407-9-176","article-title":"Chemokine Receptor CXCR4 Expression in Hepatocellular Carcinoma Patients Increases the Risk of Bone Metastases and Poor Survival","volume":"9","author":"Xiang","year":"2009","journal-title":"BMC Cancer."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0358","article-title":"Potential Prognostic Biomarkers for Bone Metastasis From Hepatocellular Carcinoma","volume":"16","author":"Xiang","year":"2011","journal-title":"Oncologist"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i11.3025","article-title":"Mass Spectrometry-Based Serum Peptide Profiling in Hepatocellular Carcinoma With Bone Metastasis","volume":"20","author":"He","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B42","article-title":"FRZB Up-Regulated in Hepatocellular Carcinoma Bone Metastasis","volume":"8","author":"Huang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13531","article-title":"MicroRNA-34a Expression Levels in Serum and Intratumoral Tissue can Predict Bone Metastasis in Patients With Hepatocellular Carcinoma","volume":"7","author":"Xiang","year":"2016","journal-title":"Oncotarget"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12844","article-title":"Clinical Outcome and Prognostic Factors in Hepatocellular Carcinoma Patients With Bone Metastases Medicated With Zoledronic Acid","volume":"47","author":"Honda","year":"2017","journal-title":"Hepatol Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12885-021-07808-6","article-title":"Serum Lnc34a is a Potential Prediction Biomarker for Bone Metastasis in Hepatocellular Carcinoma Patients","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7150\/jca.65308","article-title":"The Homogeneity and Heterogeneity of Occurrence, Characteristics, and Prognosis in Hepatocellular Carcinoma Patients With Synchronous and Metachronous Bone Metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"J Cancer."},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.32607\/20758251-2015-7-2-17-28","article-title":"Cancer Invasion: Patterns and Mechanisms","volume":"7","author":"Krakhmal","year":"2015","journal-title":"Acta Naturae."},{"key":"B48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jbo.2012.11.002","article-title":"The Role of the Bone Microenvironment in Skeletal Metastasis","volume":"2","author":"Zheng","year":"2013","journal-title":"J Bone Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2008.46","article-title":"Roles of Chemokine Receptor 4 (CXCR4) and Chemokine Ligand 12 (CXCL12) in Metastasis of Hepatocellular Carcinoma Cells","volume":"5","author":"Liu","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of Bone Metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nrc867","article-title":"Metastasis to Bone: Causes, Consequences and Therapeutic Opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105268","article-title":"Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis Survey","volume":"9","author":"Santini","year":"2014","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930500104","article-title":"Bone Metastases of Hepatocellular Carcinoma After Liver Resection","volume":"50","author":"Taki","year":"1992","journal-title":"J Surg Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyz028","article-title":"Early Detection of Bone Metastases of Hepatocellular Carcinoma Reduces Bone Fracture and Paralysis","volume":"49","author":"Hirai","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1499-3872(16)60173-X","article-title":"Bone Metastases From Hepatocellular Carcinoma: Clinical Features and Prognostic Factors","volume":"16","author":"Lu","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nature01658","article-title":"Osteoclast Differentiation and Activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast Differentiation by RANKL and OPG Signaling Pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2008.10.146","article-title":"NF-kappaB Functions in Osteoclasts","volume":"378","author":"Soysa","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical Implications of the Osteoprotegerin\/RANKL\/RANK System for Bone and Vascular Diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.11.877","article-title":"Tumour Cells Produce Receptor Activator of NF-kappaB Ligand (RANKL) in Skeletal Metastases","volume":"55","author":"Huang","year":"2002","journal-title":"J Clin Pathol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9277-4","article-title":"Receptor Activator of Nuclear factor-kappaB Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis","volume":"14","author":"Sasaki","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.162.11.1","article-title":"Expression of Receptor Activator of Nuclear factor-kappaB is Inversely Correlated With Metastatic Phenotype in Breast Carcinoma","volume":"11","author":"Bhatia","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B63","article-title":"Polymerase Chain Reaction Analysis of Parathyroid Hormone-Related Protein Gene Expression in Breast Cancer Patients and Occurrence of Bone Metastases","volume":"53","author":"Bouizar","year":"1993","journal-title":"Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00310-3","article-title":"Parathyroid Hormone-Related Peptide and Survival of Patients With Cancer and Hypercalcemia","volume":"115","author":"Truong","year":"2003","journal-title":"Am J Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb01237.x","article-title":"Parathyroid Hormone-Related Peptide Expression in Primary and Metastatic Liver Tumours","volume":"23","author":"Roskams","year":"1993","journal-title":"Histopathology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-Mediated Hypercalcemia: Causes and Survival in 138 Patients","volume":"100","author":"Donovan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.11005\/jbm.2017.24.4.249","article-title":"Clinical Characteristics, Causes and Survival in 115 Cancer Patients With Parathyroid Hormone Related Protein-Mediated Hypercalcemia","volume":"24","author":"Jin","year":"2017","journal-title":"J Bone Metab"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2001961","DOI":"10.1002\/advs.202001961","article-title":"RNF219\/alpha-Catenin\/LGALS3 Axis Promotes Hepatocellular Carcinoma Bone Metastasis and Associated Skeletal Complications","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv Sci (Weinh)."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31673","article-title":"H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha\/p38 Mitogen-Activated Protein Kinase-Dependent Manner and Sponging microRNA 200b-3p","volume":"74","author":"Huang","year":"2021","journal-title":"Hepatology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.7150\/jca.45995","article-title":"LncZEB1-AS1 Regulates Hepatocellular Carcinoma Bone Metastasis via Regulation of the miR-302b-EGFR-PI3K-AKT Axis","volume":"11","author":"Ma","year":"2020","journal-title":"J Cancer."},{"key":"B71","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-019-1044-9","article-title":"The Molecular Mechanism of LncRNA34a-Mediated Regulation of Bone Metastasis in Hepatocellular Carcinoma","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Cancer."},{"key":"B72","article-title":"Genetic Heterogeneity in Hepatocellular Carcinoma and Paired Bone Metastasis Revealed by Next-Generation Sequencing","volume":"10","author":"Jin","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12967-021-03085-w","article-title":"Role of Galectin 3 Binding Protein in Cancer Progression: A Potential Novel Therapeutic Target","volume":"19","author":"Capone","year":"2021","journal-title":"J Transl Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.23460","article-title":"Verteporfin Inhibits YAP-Induced Bladder Cancer Cell Growth and Invasion via Hippo Signaling Pathway","volume":"15","author":"Dong","year":"2018","journal-title":"Int J Med Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.184","article-title":"LncRNA-Mediated Regulation of Cell Signaling in Cancer","volume":"36","author":"Peng","year":"2017","journal-title":"Oncogene"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00353-1","article-title":"Long Noncoding RNAs in Cancer Metastasis","volume":"21","author":"Liu","year":"2021","journal-title":"Nat Rev Cancer."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.223","article-title":"Upregulation of Long Noncoding RNA ZEB1-AS1 Promotes Tumor Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.943866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T03:49:48Z","timestamp":1656474588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.943866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":77,"alternative-id":["10.3389\/fonc.2022.943866"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.943866","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"article-number":"943866"}}